Skip to main content

Advertisement

Erratum to: Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival

Article metrics

The original article was published in BMC Cancer 2015 15:441

Erratum

After publication of the original article [1], the author noticed that there are some error with Table 2 and Table 3. Please see the correct Tables below. We apologize for any inconvenience caused.

Table 2 CXCL16 and CXCR6 expression as predictors of disease-specific survival in 335 NSCLC patients
Table 3 Results of multivariate Cox regression analyses for clinicopathological factors and CXCL16 in stromal cells (model 1) and co-expression of CXCL16 in cancer and stromal cells (model 2*)

References

  1. 1.

    Hald SM, et al. Prognostic impact of CXCL16 and CXCR6 in non-small cell lung cancer: combined high CXCL16 expression in tumor stroma and cancer cells yields improved survival. BMC Cancer. 2015;15:441. doi:10.1186/s12885-015-1446-z.

Download references

Author information

Correspondence to Sigurd M. Hald.

Additional information

The online version of the original article can be found under doi:10.1186/s12885-015-1446-z.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark